USPTO serial 79306725
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Julianne Abelman
Julianne Abelman Womble Bond Dickinson (US) LLP950 3rd Avenue, Suite 2400New York, NY 10022UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry and science and adhesives used in industry | ACTIVE | — |
| 005 | Pharmaceuticals, namely, pharmaceutical preparations in the nature of a drug delivery system comprised of polymer-based capsules, pastes, gels and dispersions for the release of a wide variety of therapeutic agents; pharmaceuticals being pharmaceutical preparations in the nature of drug delivery systems comprised of polymers in the state of pastes, gels and dispersions for use in slow-dose and pulsed-dose release, drug delivery excipients in the form of polyorthoesters, polyanhydrides and other bio-erodible polymers for typically small drug molecules, drug delivery agents of polymeric nature such as amphiphilic copolymers and polymeric surfactants for the purpose of providing solubility and stability to and for difficult to solubilize drug molecule, such as biologic protein; sanitary preparations for medical purposes, namely, medical plasters and hemostatic pastes, materials for filling of wound cavity in the nature of medical hemostatic pastes, materials for dressing in the nature of self-adhesive bandages, medical adhesive tape; medical adhesive tape for closing wounds and incisions; adhesive bandages, adhesive bandages for wounds, medical adhesives for binding internal tissue, injectable or sprayable medical hemostatic gels or solutions to stop tissue bleeding; material for dental cavity filling being material for stopping teeth, dental wax, dental adhesives | ACTIVE | — |
| 010 | Surgical apparatus and instruments, medical and dental apparatus and instruments in the nature of surgical implants comprised of artificial materials and polymer in-situ curing gel and viscous gel polymer, characterized by being chemically or physically cross-linked | ACTIVE | — |
| 040 | Processing and treating materials and objects for others, namely, processing and treating of polymers, polymer compositions, polymer ingredients and polymer-additives; treatment of materials by polymerization being induced by external irradiation such as UV-light; addition of polymer additives to render materials pharmaceutically and surgically compatible; customization being the custom manufacture and manufacture of special made polymers, polymer compositions, polymer ingredients and excipients | ACTIVE | — |
| 042 | Science and technology services and research and development relating thereto, namely, scientific research, industrial research, design, development, processing scale-up and engineering, and testing services in the field of polymers, polymeric mixtures and formulations, polymer modifications and polymerization; oligomer and polymer synthesis and materials customization for medical, surgical, pharmaceutical, and cosmetic applications | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 7, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 28, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 2, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 2, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 23, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 23, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 23, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 20, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 20, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 20, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 20, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 7, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 7, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 18, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 29, 2022 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Apr 1, 2022 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Mar 28, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 28, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 28, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 28, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 28, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 22, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 21, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 21, 2022 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 23, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 23, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 23, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 3, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 2, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 2, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 31, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 8, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 6, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 5, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 4, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 24, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 23, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 19, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 18, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |